Comparison of complications and recovery after laparoscopic and abdominal hysterectomy for benign disease: the LAparoscopic Versus Abdominal hysterectomy (LAVA) randomised controlled trial

比较腹腔镜子宫切除术和开腹子宫切除术治疗良性疾病的并发症和恢复情况:腹腔镜子宫切除术与开腹子宫切除术(LAVA)随机对照试验

阅读:2

Abstract

OBJECTIVE: To compare recovery after laparoscopic hysterectomy (LH) and abdominal hysterectomy (AH). DESIGN: A parallel, open, non-inferiority, multicentre, randomised controlled, expertise-based surgery trial. SETTING: 10 NHS (National Health Service) hospitals within the UK. PARTICIPANTS: Women undergoing hysterectomy for a benign gynaecological condition. INTERVENTIONS: Consenting women of 18-55 years were randomised to LH or AH using a secure internet facility by a surgeon with self-declared expertise. Major complications were recorded by clinicians, and recovery was assessed by regular text messaging and postal questionnaires. PRIMARY AND SECONDARY OUTCOME MEASURES: Major surgical complications (Clavien-Dindo≥level 3) up to six completed weeks postsurgery, time to resumption of normal activities measured by the Patient-Reported Outcomes Measurement Information System Physical Function tool and quality of recovery at 24 hours (Quality of Recovery 15 score; 0-150). RESULTS: 75 women were randomised before early curtailment of the trial; 32/39 (82%) and 30/36 (83%) women underwent LH and AH, respectively. Major complications occurred in 2/32 (6%) LH versus 4/30 (13%) AH groups. No difference in time to resumption of usual activities was found (median [IQR, n] 7.5 weeks (3.6-8.2, 25) LH vs 7.5 weeks (5.5-10.6, 26) AH groups or quality of recovery (mean [SD, n] 81.1 (13.4, 27) vs 72.3 (17.6, 22), respectively; adjusted mean difference 7.2, 95% CI -3.2 to 17.6). CONCLUSIONS: No differences were found in complications or recovery between LH and AH. However, early cessation of the trial due to recruitment challenges limits clinical inferences. It is important that larger comparative trials are conducted now that LH, including robotics, is becoming adopted as standard practice. TRIAL REGISTRATION NUMBER: ISRCTN14566195, IRAS ID 287988.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。